logo
Woodside Completes Louisiana LNG Sell-Down to Stonepeak

Woodside Completes Louisiana LNG Sell-Down to Stonepeak

Yahoo25-06-2025
HOUSTON, June 25, 2025--(BUSINESS WIRE)--Woodside is pleased to announce the completion of the sell-down of a 40% interest in Louisiana LNG Infrastructure LLC to Stonepeak, a leading global investment firm specialising in infrastructure and real assets.
The completion follows Woodside's announcement on 7 April 2025 that it had signed an agreement with Stonepeak, enhancing Louisiana LNG economics and strengthening Woodside's near-term capacity for shareholder returns.1
Under the transaction, Stonepeak will provide US$5.7 billion towards the expected capital expenditure for the foundation development of Louisiana LNG on an accelerated basis, contributing 75% of project capital expenditure in both 2025 and 2026.
The closing payment of approximately US$1.9 billion received by Woodside reflects Stonepeak's 75% share of capex funding incurred since the effective date of 1 January 2025.
Woodside CEO Meg O'Neill said Stonepeak would add further value to the Louisiana LNG Project.
"Our partnership with Stonepeak reflects the attractiveness of Louisiana LNG and was a key milestone towards achieving a successful final investment decision. Stonepeak is a high-quality partner, with extensive investment experience across US gas and LNG infrastructure.
"The accelerated capital contribution from Stonepeak enhances Louisiana LNG project returns and strengthens our capacity for shareholder returns ahead of first cargo from the Scarborough Energy Project in Western Australia, targeted for the second half of 2026.
"We continue to see strong interest from additional potential partners in Louisiana LNG."
Stonepeak Senior Managing Director and Head of US Private Equity James Wyper said the company was pleased to be working with Woodside.
"Louisiana LNG will be a timely and strategic addition to the US LNG export landscape as the world's demand for cleaner, more flexible and more affordable energy continues to grow.
"We look forward to contributing our expertise and capital to the construction and future operation of Louisiana LNG and are highly energised to continue supporting the development of critical North American LNG infrastructure with global impact."
About Stonepeak
Stonepeak is a leading alternative investment firm specialising in infrastructure and real assets with approximately US$73 billion of assets under management. Through its investment in defensive, hard-asset businesses globally, Stonepeak aims to create value for its investors and portfolio companies, with a focus on downside protection and strong risk-adjusted returns.
Stonepeak, as sponsor of private equity and credit investment vehicles, provides capital, operational support, and committed partnership to grow investments in its target sectors, which include digital infrastructure, energy and energy transition, transport and logistics, and real estate. Stonepeak is headquartered in New York with offices in Houston, Washington, DC, London, Hong Kong, Seoul, Singapore, Sydney, Tokyo, Abu Dhabi, and Riyadh.
About Louisiana LNG
Louisiana LNG is a fully permitted LNG project located near Lake Charles, Louisiana, with total permitted capacity of 27.6 million tonnes per annum (Mtpa) across five trains.
The approved foundation project includes three trains with a combined capacity of 16.5 Mtpa and achieved a successful final investment decision in April 2025.
Bechtel is the engineering, procurement and construction contractor, under a lump sum, turnkey agreement. The facility utilises the Chart IPSMR® liquefaction technology and Baker Hughes LM6000PF+ gas turbines.
This announcement was approved and authorised for release by Woodside's Disclosure Committee.
Forward-looking statements
This announcement contains forward-looking statements with respect to Woodside's business and operations, market conditions, results of operations and financial condition, including, for example, but not limited to, statements regarding the transaction (including statements concerning the expected benefits of the transaction and other future arrangements between the parties) expectations regarding future expenditures and future results of projects. All forward-looking statements contained in this announcement reflect Woodside's views held as at the date of this announcement. All statements, other than statements of historical or present facts, are forward-looking statements and generally may be identified by the use of forward-looking words such as 'guidance', 'foresee', 'likely', 'potential', 'anticipate', 'believe', 'aim', 'estimate', 'expect', 'intend', 'may', 'target', 'plan', 'forecast', 'project', 'schedule', 'will', 'should', 'seek' and other similar words or expressions.
Forward-looking statements in this announcement are not guidance, forecasts, guarantees or predictions of future events or performance, but are in the nature of aspirational targets that Woodside has set for itself and its management of the business. Those statements and any assumptions on which they are based are only opinions, are subject to change without notice and are subject to inherent known and unknown risks, uncertainties, assumptions and other factors, many of which are beyond the control of Woodside, its related bodies corporate and their respective officers, directors, employees, advisers or representatives.
Details of the key risks relating to Woodside and its business can be found in the "Risk" section of Woodside's most recent Annual Report released to the Australian Securities Exchange and Woodside's most recent Annual Report on Form 20-F filed with the United States Securities and Exchange Commission and available on the Woodside website at https://www.woodside.com/investors/reports-investor-briefings. You should review and have regard to these risks when considering the information contained in this announcement.
Investors are strongly cautioned not to place undue reliance on any forward-looking statements. Actual results or performance may vary materially from those expressed in, or implied by, any forward-looking statements.
All information included in this announcement, including any forward-looking statements, speak only as of the date of this announcement and, except as required by law or regulation, Woodside does not undertake to update or revise any information or forward-looking statements contained in this announcement, whether as a result of new information, future events, or otherwise.
Other important information
All references to dollars, cents or $ in this announcement are to US currency, unless otherwise stated. References to "Woodside" may be references to Woodside Energy Group Ltd and/or its applicable subsidiaries (as the context requires).
1 See "Woodside announces Louisiana LNG partnership with Stonepeak" announced on 7 April 2025 for details.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250624819158/en/
Contacts
INVESTORS Sarah PeymanM: +61 457 513 249E: investor@woodside.com
MEDIA Dan PagodaM: +61 482 675 731E: dan.pagoda@woodside.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

PG&E Second Quarter 2025 Earnings: Misses Expectations
PG&E Second Quarter 2025 Earnings: Misses Expectations

Yahoo

time14 minutes ago

  • Yahoo

PG&E Second Quarter 2025 Earnings: Misses Expectations

PG&E (NYSE:PCG) Second Quarter 2025 Results Key Financial Results Revenue: US$5.90b (down 1.5% from 2Q 2024). Net income: US$521.0m (flat on 2Q 2024). Profit margin: 8.8% (up from 8.7% in 2Q 2024). The increase in margin was driven by lower expenses. EPS: US$0.24. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period PG&E Revenues and Earnings Miss Expectations Revenue missed analyst estimates by 5.5%. Earnings per share (EPS) also missed analyst estimates by 22%. Looking ahead, revenue is forecast to grow 3.4% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Electric Utilities industry in the US. Performance of the American Electric Utilities industry. The company's share price is broadly unchanged from a week ago. Risk Analysis Be aware that PG&E is showing 1 warning sign in our investment analysis that you should know about... Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio

I Asked ChatGPT What Would Happen if Trump Ended Income Taxes — There's Good News and Bad News
I Asked ChatGPT What Would Happen if Trump Ended Income Taxes — There's Good News and Bad News

Yahoo

time14 minutes ago

  • Yahoo

I Asked ChatGPT What Would Happen if Trump Ended Income Taxes — There's Good News and Bad News

No one likes paying taxes. Maybe that's why President Donald Trump has proposed nixing the income tax altogether in favor of tariffs. Tariffs, he believes, would make us so rich we could all kiss the tax man goodbye — at least the income tax man. Tariffs are basically a tax, paid by the importer, and passed onto the consumer. Learn More: Find Out: But what would things really look like if income taxes were a thing of the past? We asked ChatGPT. It had four main points. Constitutional Viability Could Trump put an end to income taxes by executive order or another unilateral way? That, said ChatGPT, is a hard no. 'Income taxes are codified in the 16th Amendment to the Constitution (1913), which explicitly authorizes the federal government to levy income taxes without apportioning them among the states,' it said. Abolishing income taxes would require legislation from Congress, with a two-thirds vote by both houses. With that stated, it's not likely to happen. Read Next: Budgetary Reality The fact is, individual and corporate income taxes have made up the bulk of federal revenue for the past 50 years, according to the Bipartisan Policy Center. ChatGPT noted that equals $2.2 trillion in personal federal income tax, and $460 billion from corporate income tax, per 2023 figures. The Bipartisan Policy Center puts the figures at $2.4 trillion and $530 billion, respectively. Either way, it's a lot of money, with personal income taxes making up for 49% of total federal government revenue, and corporate income taxes making up 11%. Wipe them out, and the federal government loses 60% of its income. Tariffs, on the other hand, bring in a mere $98 billion, according to ChatGPT — NPR put the figure for the fiscal year ending September of 2024 at $80 billion. Politico, which tracks the tariff income, reported that this year, U.S. tariffs, which include Trump's tariffs, have brought in $100.5 billion as of July 13 — $53 billion more than at this time last year. That is not going to cut it, according to ChatGPT: 'Tariffs would need to be increased more than 20-fold to make up for the loss [in income tax].' It added that everything would have to be tariffed — all consumer goods, tech products, energy and industrial goods — at rates that would be inflationary and spark massive trade wars. Economic and Social Impact ChatGPT did throw some pros in with the cons. Hypothetically, it said, no federal income tax would make all our lives easier, simplifying the month of April. Taxing spending — retail, tariffs, etc. — might also benefit some groups that spend little compared to their income, ChatGPT said. For instance, this would include high earners who are somewhat restrained in their spending and frugal retirees. Now for the flip side. Tariffs and sales taxes are regressive, ChatGPT explained. It disproportionately hits low- and middle-income households who spend more of their income — as a percentage — than the wealthy. In other words, buying a book or computer or car is a larger percentage of income to someone making $50,000 a year than to someone making $5 million. Additionally, because of the shortfall in federal revenue, massive budget cuts would be required. Large cuts to Medicaid and Medicare would be required — much larger than the ones in the One Big Beautiful Bill — in addition to the military and other entitlements and services. So, Would We All Be Richer? According to ChatGPT, that's another hard no (in bold, no less). It claims that according to 'almost all mainstream economists,' tariffs raise prices, reduce efficiency and can hurt job growth. In addition, ending the income tax would destabilize public finances and increase inequality. The move would benefit the wealthy and hurt the poor. For his part, Trump believes that the period between 1870 to 1913, before income taxes were a thing and when tariffs were a very big thing, was America's Golden Age. On April 15, he told Fox Noticias it was that era when we were our richest. That's debatable at best, and very much depends on who you define as 'we.' After all, Mark Twain coined it as the Gilded Age for its massive corruption and rampant inequality. The wealthy were very wealthy, to be sure, but according to Digital History, supported by a consortium of government, university and public organizations, in 1877, the average annual income of an urban family was $738 ($22,594 in today's money). After housing, food, heating and clothing, an average of $44 per year ($1,347) was left over for fun, emergencies and retirement savings — and without Social Security, they'd need it. For that, the average unskilled or semi-skilled person worked 10 hours a day for 20 cents ($6.12) per hour, and 939 out of 1,000 died with no property to pass on to heirs. Frankly, that's not sounding very golden. More From GOBankingRates 3 Reasons Retired Boomers Shouldn't Give Their Kids a Living Inheritance (And 2 Reasons They Should) This article originally appeared on I Asked ChatGPT What Would Happen if Trump Ended Income Taxes — There's Good News and Bad News Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

3 Reasons to Buy Medtronic Stock
3 Reasons to Buy Medtronic Stock

Yahoo

time14 minutes ago

  • Yahoo

3 Reasons to Buy Medtronic Stock

Key Points Medtronic is separating out its lower-margin diabetes care segment. It's also pouncing on a massive opportunity in robotic-assisted surgery. The healthcare leader has a terrific dividend-growth track record. 10 stocks we like better than Medtronic › Medical device specialist Medtronic (NYSE: MDT) has not been the best of investments over the past five years. The stock has significantly lagged the market over this period, thanks to weak business fundamentals, including slow revenue growth. The healthcare giant now faces additional obstacles, such as the threat of steeper tariffs due to President Donald Trump's aggressive trade policies. Even amid all that, Medtronic has plenty of redeeming qualities and could still be a solid investment for long-term investors. Here are three reasons why. 1. Medtronic is spinning off its diabetes care unit Medtronic recently announced that it will be spinning off its diabetes care unit, which will become a stand-alone, publicly traded company. Although sales of diabetes products have been growing faster than the rest of Medtronic's business, they have also been a drag on margins. During the company's fiscal year 2025, which ended on April 25, diabetes care accounted for 8% of revenue but only 4% of operating profits. Medtronic's other segments are not growing their sales as quickly, but they have more profitable margins. In an environment where the company may face higher manufacturing costs due to tariffs, management has chosen to focus on higher-margin opportunities. Diabetes care was also the healthcare specialist's only consumer-facing business; the others offer products to healthcare providers. The move could help Medtronic navigate the macroeconomic landscape better if Trump's tariffs remain in place. That's especially the case if the company can find other lucrative revenue growth opportunities. 2. A significant opportunity in robotic-assisted surgery Medtronic has been developing its robotic-assisted surgery (RAS) system, Hugo, for years. It has been in use in other countries, though it's yet to get the regulatory nod in the United States. The medical device specialist decided to pursue this opportunity because the RAS market is severely underpenetrated. Intuitive Surgical's da Vinci system dominates the field and faces little competition for the range of procedures for which it's approved. Yet a couple of years ago, Medtronic pointed out that of all the procedures that could be performed robotically, fewer than 5% were. And over the long run, the demand for these kinds of surgeries will increase along with the world's aging population, since seniors are far more likely to face health issues that call for these kinds of interventions. The good news is that Medtronic's Hugo system recently completed clinical trials in the U.S. for urologic procedures. The company has requested clearance from the U.S. Food and Drug Administration for that indication. It should be the first of many. The Hugo system could eventually become a crucial part of Medtronic's growth strategy and help improve its financial results over the long term, given the significant white space available in the industry. 3. A soon-to-be Dividend King Despite Medtronic's recent challenges, the company has continued to pay and raise its dividends. In fact, the company has raised dividends for 48 consecutive years. Most businesses don't survive nearly five decades, let alone pay dividends for that long. Medtronic's ability to do so speaks volumes about its underlying business. It's a well-established leader in its niche of the healthcare market, with significant footprint in the industry and a long and successful history of navigating this deeply regulated sector. All of those factors make Medtronic an excellent pick for income-seeking investors. It should continue rewarding shareholders with payout increases for a long time -- and in two years, it should become a Dividend King. Medtronic may not be one of the most exciting artificial intelligence (AI) leaders capturing Wall Street's attention, although the company is implementing AI across its business in ways that could pay off in the long run. Regardless, its recent moves in shedding its diabetes care segment and seeking clearance for its Hugo system, along with its consistent dividend streak, make Medtronic a reliable company to invest in for the long haul. Do the experts think Medtronic is a buy right now? The Motley Fool's expert analyst team, drawing on years of investing experience and deep analysis of thousands of stocks, leverages our proprietary Moneyball AI investing database to uncover top opportunities. They've just revealed their to buy now — did Medtronic make the list? When our Stock Advisor analyst team has a stock recommendation, it can pay to listen. After all, Stock Advisor's total average return is up 1,019% vs. just 178% for the S&P — that is beating the market by 841.12%!* Imagine if you were a Stock Advisor member when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $624,823!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,064,820!* The 10 stocks that made the cut could produce monster returns in the coming years. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Prosper Junior Bakiny has positions in Intuitive Surgical. The Motley Fool has positions in and recommends Intuitive Surgical. The Motley Fool recommends Medtronic and recommends the following options: long January 2026 $75 calls on Medtronic and short January 2026 $85 calls on Medtronic. The Motley Fool has a disclosure policy. 3 Reasons to Buy Medtronic Stock was originally published by The Motley Fool

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store